Selected research
Market Structure
Global Ambrisentan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ambrisentan Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ambrisentan Drug include Gilead Sciences, Hansoh Pharma and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Ambrisentan Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ambrisentan Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ambrisentan Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Ambrisentan Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Ambrisentan Drug Segment by Company
Gilead Sciences
Hansoh Pharma
GSK
Ambrisentan Drug Segment by Type
5 mg Tablet
10 mg Tablet
Ambrisentan Drug Segment by Application
Hospital
Drug store
Ambrisentan Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambrisentan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ambrisentan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambrisentan Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Ambrisentan Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ambrisentan Drug industry.
Chapter 3: Detailed analysis of Ambrisentan Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ambrisentan Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg Tablet
- 10 mg Tablet
Applications
- Hospital
- Drug store
Companies covered
- Gilead Sciences
- Hansoh Pharma
- GSK
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Ambrisentan Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 5 mg Tablet
- 1.2.3 10 mg Tablet
- 1.3 Market Analysis by Application
- 1.3.1 Global Ambrisentan Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Global Market Growth Prospects
- 1.5 Global Ambrisentan Drug Growth Trends by Region
- 1.5.1 Global Ambrisentan Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Ambrisentan Drug Market Size by Region (2021-2026)
- 1.5.3 Ambrisentan Drug Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Ambrisentan Drug Market Dynamics
- 2.1 Ambrisentan Drug Industry Trends
- 2.2 Ambrisentan Drug Industry Drivers
- 2.3 Ambrisentan Drug Industry Opportunities and Challenges
- 2.4 Ambrisentan Drug Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Ambrisentan Drug Revenue by Company (2021-2026)
- 3.2 Global Ambrisentan Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Ambrisentan Drug Key Company Head office and Area Served
- 3.4 Global Ambrisentan Drug Company, Product Type & Application
- 3.5 Global Ambrisentan Drug Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Ambrisentan Drug Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Ambrisentan Drug Players Market Share by Revenue in 2025
- 3.6.3 2025 Ambrisentan Drug Tier 1, Tier 2, and Tier 3
4 Ambrisentan Drug Market by Type
- 4.1 Global Ambrisentan Drug Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Ambrisentan Drug Market Size by Type (2021-2032)
- 4.3 Global Ambrisentan Drug Market Size Share by Type (2021-2032)
5 Ambrisentan Drug Market by Application
- 5.1 Global Ambrisentan Drug Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Ambrisentan Drug Market Size by Application (2021-2032)
- 5.3 Global Ambrisentan Drug Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Gilead Sciences
- 6.1.1 Gilead Sciences Company Information
- 6.1.2 Gilead Sciences Business Overview
- 6.1.3 Gilead Sciences Ambrisentan Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Gilead Sciences Ambrisentan Drug Product Portfolio
- 6.1.5 Gilead Sciences Recent Developments
- 6.2 Hansoh Pharma
- 6.2.1 Hansoh Pharma Company Information
- 6.2.2 Hansoh Pharma Business Overview
- 6.2.3 Hansoh Pharma Ambrisentan Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Hansoh Pharma Ambrisentan Drug Product Portfolio
- 6.2.5 Hansoh Pharma Recent Developments
- 6.3 GSK
- 6.3.1 GSK Company Information
- 6.3.2 GSK Business Overview
- 6.3.3 GSK Ambrisentan Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GSK Ambrisentan Drug Product Portfolio
- 6.3.5 GSK Recent Developments
7 North America
- 7.1 North America Ambrisentan Drug Market Size (2021-2032)
- 7.2 North America Ambrisentan Drug Market Size by Type
- 7.2.1 North America Ambrisentan Drug Market Size by Type (2021-2026)
- 7.2.2 North America Ambrisentan Drug Market Size by Type (2027-2032)
- 7.2.3 North America Ambrisentan Drug Market Share by Type (2021-2032)
- 7.3 North America Ambrisentan Drug Market Size by Application
- 7.3.1 North America Ambrisentan Drug Market Size by Application (2021-2026)
- 7.3.2 North America Ambrisentan Drug Market Size by Application (2027-2032)
- 7.3.3 North America Ambrisentan Drug Market Share by Application (2021-2032)
- 7.4 North America Ambrisentan Drug Market Size by Country
- 7.4.1 North America Ambrisentan Drug Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Ambrisentan Drug Market Size by Country (2021-2026)
- 7.4.3 North America Ambrisentan Drug Market Size by Country (2027-2032)
- 7.4.4 North America Ambrisentan Drug Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Ambrisentan Drug Market Size (2021-2032)
- 8.2 Europe Ambrisentan Drug Market Size by Type
- 8.2.1 Europe Ambrisentan Drug Market Size by Type (2021-2026)
- 8.2.2 Europe Ambrisentan Drug Market Size by Type (2027-2032)
- 8.2.3 Europe Ambrisentan Drug Market Share by Type (2021-2032)
- 8.3 Europe Ambrisentan Drug Market Size by Application
- 8.3.1 Europe Ambrisentan Drug Market Size by Application (2021-2026)
- 8.3.2 Europe Ambrisentan Drug Market Size by Application (2027-2032)
- 8.3.3 Europe Ambrisentan Drug Market Share by Application (2021-2032)
- 8.4 Europe Ambrisentan Drug Market Size by Country
- 8.4.1 Europe Ambrisentan Drug Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Ambrisentan Drug Market Size by Country (2021-2026)
- 8.4.3 Europe Ambrisentan Drug Market Size by Country (2027-2032)
- 8.4.4 Europe Ambrisentan Drug Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Ambrisentan Drug Market Size (2021-2032)
- 9.2 China Ambrisentan Drug Market Size by Type
- 9.2.1 China Ambrisentan Drug Market Size by Type (2021-2026)
- 9.2.2 China Ambrisentan Drug Market Size by Type (2027-2032)
- 9.2.3 China Ambrisentan Drug Market Share by Type (2021-2032)
- 9.3 China Ambrisentan Drug Market Size by Application
- 9.3.1 China Ambrisentan Drug Market Size by Application (2021-2026)
- 9.3.2 China Ambrisentan Drug Market Size by Application (2027-2032)
- 9.3.3 China Ambrisentan Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Ambrisentan Drug Market Size (2021-2032)
- 10.2 Asia Ambrisentan Drug Market Size by Type
- 10.2.1 Asia Ambrisentan Drug Market Size by Type (2021-2026)
- 10.2.2 Asia Ambrisentan Drug Market Size by Type (2027-2032)
- 10.2.3 Asia Ambrisentan Drug Market Share by Type (2021-2032)
- 10.3 Asia Ambrisentan Drug Market Size by Application
- 10.3.1 Asia Ambrisentan Drug Market Size by Application (2021-2026)
- 10.3.2 Asia Ambrisentan Drug Market Size by Application (2027-2032)
- 10.3.3 Asia Ambrisentan Drug Market Share by Application (2021-2032)
- 10.4 Asia Ambrisentan Drug Market Size by Country
- 10.4.1 Asia Ambrisentan Drug Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Ambrisentan Drug Market Size by Country (2021-2026)
- 10.4.3 Asia Ambrisentan Drug Market Size by Country (2027-2032)
- 10.4.4 Asia Ambrisentan Drug Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Ambrisentan Drug Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Ambrisentan Drug Market Size by Type
- 11.2.1 South America, Middle East & Africa Ambrisentan Drug Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Ambrisentan Drug Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Ambrisentan Drug Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Ambrisentan Drug Market Size by Application
- 11.3.1 South America, Middle East & Africa Ambrisentan Drug Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Ambrisentan Drug Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Ambrisentan Drug Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Ambrisentan Drug Market Size by Country
- 11.4.1 South America, Middle East & Africa Ambrisentan Drug Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Ambrisentan Drug Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Ambrisentan Drug Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Ambrisentan Drug Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst